Advertisement
SVRA vs TARS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVRA is a Hold and TARS is a StrongBuy.
SVRA in upward trend: price may jump up because it broke its lower Bollinger Band on October 23, 2026
SVRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 35 of 40 cases where SVRA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SVRA's RSI Oscillator exited the oversold zone, 16 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on SVRA as a result. In 73 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for SVRA just turned positive on October 27, 2026. Looking at past instances where SVRA's MACD turned positive, the stock continued to rise in 29 of 42 cases over the following month. The odds of a continued upward trend are 69%.
Following a +15.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where SVRA advanced for three days, in 191 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
SVRA moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SVRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for SVRA entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 44 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. SVRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.908) is normal, around the industry mean (3.498). P/E Ratio (-8.328) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Momentum Indicator for TARS turns positive, indicating new upward trend
TARS saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In 70 of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 48 cases where TARS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for TARS just turned positive on November 10, 2026. Looking at past instances where TARS's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.
Following a +7.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where TARS advanced for three days, in 229 of 283 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
TARS moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TARS crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TARS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
TARS broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TARS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.258) is normal, around the industry mean (3.498). TARS has a moderately low P/E Ratio (-64.112) as compared to the industry average of (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (5.498) is also within normal values, averaging (440.869).
The Tickeron Profit vs. Risk Rating rating for this company is 25 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. TARS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
SVRA | TARS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 62 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 44 | 25 | |
SMR RATING 1..100 | 99 | 94 | |
PRICE GROWTH RATING 1..100 | 51 | 52 | |
P/E GROWTH RATING 1..100 | 30 | 74 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TARS's Valuation (3) in the null industry is significantly better than the same rating for SVRA (69) in the Biotechnology industry. This means that TARS’s stock grew significantly faster than SVRA’s over the last 12 months.
TARS's Profit vs Risk Rating (25) in the null industry is in the same range as SVRA (44) in the Biotechnology industry. This means that TARS’s stock grew similarly to SVRA’s over the last 12 months.
TARS's SMR Rating (94) in the null industry is in the same range as SVRA (99) in the Biotechnology industry. This means that TARS’s stock grew similarly to SVRA’s over the last 12 months.
SVRA's Price Growth Rating (51) in the Biotechnology industry is in the same range as TARS (52) in the null industry. This means that SVRA’s stock grew similarly to TARS’s over the last 12 months.
SVRA's P/E Growth Rating (30) in the Biotechnology industry is somewhat better than the same rating for TARS (74) in the null industry. This means that SVRA’s stock grew somewhat faster than TARS’s over the last 12 months.
| SVRA | TARS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 84% | N/A |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 77% |
| Momentum ODDS (%) | 2 days ago 74% | 2 days ago 84% |
| MACD ODDS (%) | 2 days ago 69% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 79% |
| Advances ODDS (%) | 3 days ago 79% | 2 days ago 81% |
| Declines ODDS (%) | 7 days ago 83% | 7 days ago 83% |
| BollingerBands ODDS (%) | 2 days ago 88% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 83% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SVRA’s FA Score shows that 1 FA rating(s) are green while TARS’s FA Score has 2 green FA rating(s).
- SVRA’s FA Score: 1 green, 4 red.
- TARS’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SVRA’s TA Score shows that 5 TA indicator(s) are bullish while TARS’s TA Score has 4 bullish TA indicator(s).
- SVRA’s TA Score: 5 bullish, 4 bearish.
- TARS’s TA Score: 4 bullish, 5 bearish.
Price Growth
SVRA (@Biotechnology) experienced а +3.58% price change this week, while TARS (@Biotechnology) price change was +1.64% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -2.90%, and the average quarterly price growth was -13.48%.
Reported Earning Dates
SVRA is expected to report earnings on Nov 11, 2026.
TARS is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Biotechnology (+4.76% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
SVRA and
Correlation & Price change
A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with FDMT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then FDMT could also see price increases.
| Ticker / NAME | Correlation To SVRA | 1D Price Change % | ||
|---|---|---|---|---|
| SVRA | 100% | -2.57% | ||
| FDMT - SVRA | 51% Loosely correlated | -0.16% | ||
| MGTX - SVRA | 47% Loosely correlated | +1.37% | ||
| ANNX - SVRA | 46% Loosely correlated | -0.47% | ||
| KURA - SVRA | 45% Loosely correlated | N/A | ||
| CLDX - SVRA | 44% Loosely correlated | -1.89% | ||
More | ||||
TARS and
Correlation & Price change
A.I.dvisor indicates that over the last year, TARS has been loosely correlated with PTGX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TARS jumps, then PTGX could also see price increases.
| Ticker / NAME | Correlation To TARS | 1D Price Change % | ||
|---|---|---|---|---|
| TARS | 100% | +4.22% | ||
| PTGX - TARS | 45% Loosely correlated | +0.26% | ||
| ARVN - TARS | 40% Loosely correlated | +2.37% | ||
| SVRA - TARS | 40% Loosely correlated | -2.57% | ||
| MGTX - TARS | 40% Loosely correlated | +1.37% | ||
| BLTE - TARS | 39% Loosely correlated | -0.74% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PQJL | 31.00 | N/A | N/A |
| PGIM NASDAQ-100 BUFFER 12 ETF - JULY | |||
| VSDM | 75.94 | -0.10 | -0.14% |
| Vanguard Short Duration Tax-Exempt Bond ETF (VSDM) | |||
| EMCB | 64.03 | -0.23 | -0.36% |
| WisdomTree Emerging Markets Corporate Bond Fund (EMCB) | |||
| RGYY | 4.78 | -0.04 | -0.93% |
| GraniteShares YieldBoost RGTI ETF (RGYY) | |||
| NAN | 10.10 | -0.18 | -1.75% |
| Nuveen New York Quality Municipal Income Fund | |||